Patent Law Weblog
recent posts
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
- United States Files Statement of Interest in Patent Infringement Proceedings
about
Month: April 2012
-
By Andrew Williams — In a second case involving the Hatch-Waxman regulatory scheme decided by the Federal Circuit on Monday, the Court held in Bayer Schering Pharma AG v. Lupin, Ltd. that for an ANDA filing to infringe a method-of-use claim, the proposed label must indicate that the FDA has determined that the drug is…
-
By Sherri Oslick — In an effort to catch up with recently filed biotech and pharma cases, Patent Docs presents this additional installment of Court Report. Allergan, Inc., et al. v. Watson Pharmaceuticals, Inc., et al.1:12-cv-00321; filed March 30, 2012 in the Middle District of North Carolina • Plaintiffs: Allergan, Inc.; Duke University• Defendants: Watson…
-
By Kevin E. Noonan — In a decision ripe for Supreme Court review (appropriately, this time), a fractured Federal Circuit delivered a plurality opinion in Marine Polymer Technologies, Inc. v. Hemcon, Inc. (Fed. Cir. 2012) (en banc). The case revealed a deep division between judges taking a strict constructionist view of the patent statute (in…
-
By Andrew Williams — On Monday, in Dey Pharma, LP v. Sunovion Pharmaceuticals Inc., the Federal Circuit affirmed a District Court's conclusion that it had subject-matter jurisdiction over a declaratory judgment action of a second ANDA filer, and as a result also affirmed the District Court's final judgment of non-infringement (based on a stipulation of…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Horizon Pharma Inc. et al. v. Par Pharmaceutical Companies Inc. et al.1:12-cv-00393; filed March 28, 2012 in the District Court of Delaware • Plaintiffs: Horizon Pharma Inc.; Horizon Pharma USA Inc.• Defendants: Par Pharmaceutical Companies…
-
April 16-18, 2012 – Intellectual Property Counsels Committee (IPCC) Spring Conference & Meeting (Biotechnology Industry Organization) – Austin, TX April 17, 2012 – 28th Annual Joint Patent Practice Seminar (Connecticut, New Jersey, New York, and Philadelphia Intellectual Property Law Associations) – New York, NY April 18, 2012 – European Biotech Patent Law Update (D Young…
-
Practising Law Institute (PLI) will be holding its Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing seminar on May 16-18, 2012 in Chicago, IL, on June 13-15, 2012 in New York, NY, and on July 11-13, 2012 in San Francisco, CA. The three-day program, which is directed to patent…
-
The Biotechnology Industry Organization (BIO) will be holding its annual BIO International Convention on June 18-21, 2012 in Boston, MA. Founded in 1993, BIO is a nonprofit association seeking supportive biotechnology policies on behalf of more than 1,100 biotechnology companies, state and international affiliates, and related organizations, as well as providing business development services for…
-
Elsevier Business Intelligence, CHI-California Healthcare Institute, and Merrill Datasite® will be offering a webinar entitled "Patent Reform Strategies in the Life Sciences: Assessing 'First-to-File' and Freedom to Operate under the New Rules" on May 2, 2012 from 1:00 – 2:00 pm (EDT). Steven C. Carlson of Fish & Richardson will provide a focused overview of…
-
The Intellectual Property Owners Association (IPO) European Practice Committee will be hosting a one-day conference entitled "The America Invents Act and Beyond: International Grace Period and Post–Grant Review" on May 10, 2012 in Brussels, Belgium. The conference will offer presentations on the following topics: Morning Session: International Grace Period• The View from the Consumer Industry…
Patent Docs 